This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
Related to this article
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Advertisement
Advertisement
Trending on Drug Topics
1
Pricing Formulas Multiply, Pharmacists Translate Complexity Into Care
2
Model Finds NHS England–Style Diabetes Prevention Program Cost-Effective
3
The Pharmacist's Expanding Role in COVID-19 Vaccine Confidence
4
Diabetes Medication Adherence Lags for Black and Hispanic Medicare Patients
5